EU OKs Abbott's $25B Acquisition Of St. Jude With Caveats
The European Commission said Wednesday it had given the green light to Abbott Laboratories' $25 billion cash-and-stock acquisition of device maker St. Jude Medical so long as Abbott divests two devices...To view the full article, register now.
Already a subscriber? Click here to view full article